Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual Agonists [Internet]
Both are used in gut health research contexts
Prescription weight loss medications, including GLP-1s, are considered safe when used under medical supervision
The median progression-free survival (mPFS) was 6.9 months (95% CI: 5.5, 8.4), and the median duration of response (mDOR) was 9.7 months (95% CI: 5.8, 11.7)
Tuning the signal: ATP-sensitive K (+) channels direct blood flow to cerebral capillaries
An evidence-based approach, like the one used in our sports injury care, prioritizes treatments that are proven to work and, just as importantly, are understood to be safe for long-term health